Page 1 | Search Results | Blood | American Society of Hematology

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Sonja G Genadieva Stavrik, MDPhD, Ariane Boumendil, Kirsty Thomson, Javier Briones, MD, Paolo Corradini, MD, Andrea Bacigalupo, MD, Gerard Socie, Guiseppe Bandini, Herve Finel, Andrea Velardi, MD, Michael Potter, PhD, Bruno Benedetto, Luca Castagna, MD, Charles Craddock, MDPhD, Nigel Russell, Peter Dreger, MD, Sureda Anna

Blood (2014) 124 (21): 2562.

https://doi.org/10.1182/blood.V124.21.2562.2562

Published: 2014

Journal Articles

Autologous Hematopoetic Stem Cell Transplantation as An Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myeloid Leukemia.

Sonja G Genadieva-Stavrik, MD, PhD, Alexandra Pivkova, Zlate Stojanoski, Svetlana Krstevska-Balkanov, Borce Georgievski

Blood (2010) 116 (21): 4595.

https://doi.org/10.1182/blood.V116.21.4595.4595

Published: 2010

Journal Articles

Initial Treatment of CD20+ Lymphocyte Predominant Hodgkin Lymphoma with Chemotherapy and the Monoclonal Antibody Rituximab-Mabthera Is Effective and Well Tolerated - Case Report.

Sonja G. Genadieva-Stavrik, PhD, Lubomir Ivkovski, PhD, Aleksandra Pivkova, MD, Lidija Cevreska, PhD

Blood (2006) 108 (11): 4696.

https://doi.org/10.1182/blood.V108.11.4696.4696

Published: 2006

Journal Articles

Prognostic Model for Aggressive Non-Hodgkin Lymphoma.

Sonja G. Genadieva-Stavrik, PhD, Ljube G. Ivkovsi, PhD, Gorgi D. Zografski, PhD, Borce A. Georgievski, PhD, Zlate R. Stojanoski, MD, Aleksandra T. Pivkova, MD, Lidija A. Cevreska, PhD

Blood (2005) 106 (11): 4689.

https://doi.org/10.1182/blood.V106.11.4689.4689

Published: 2005

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Autologous Hematopoetic Stem Cell Transplantation as An Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myeloid Leukemia.

Initial Treatment of CD20+ Lymphocyte Predominant Hodgkin Lymphoma with Chemotherapy and the Monoclonal Antibody Rituximab-Mabthera Is Effective and Well Tolerated - Case Report.

Prognostic Model for Aggressive Non-Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Update search

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Autologous Hematopoetic Stem Cell Transplantation as An Intensive Consolidation Therapy for Adult Patients in Remission from Acute Myeloid Leukemia.

Initial Treatment of CD20+ Lymphocyte Predominant Hodgkin Lymphoma with Chemotherapy and the Monoclonal Antibody Rituximab-Mabthera Is Effective and Well Tolerated - Case Report.

Prognostic Model for Aggressive Non-Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only